Half-Sandwich Ir(III) Complex of N1-Pyridyl-7-azaindole Exceeds Cytotoxicity of Cisplatin at Various Human Cancer Cells and 3D Multicellular Tumor Spheroids

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F18%3A73591068" target="_blank" >RIV/61989592:15310/18:73591068 - isvavai.cz</a>

Result on the web

<a href="https://pubs.acs.org/doi/pdf/10.1021/acs.organomet.8b00415" target="_blank" >https://pubs.acs.org/doi/pdf/10.1021/acs.organomet.8b00415</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1021/acs.organomet.8b00415" target="_blank" >10.1021/acs.organomet.8b00415</a>

Result language

angličtina

Original language name

Half-Sandwich Ir(III) Complex of N1-Pyridyl-7-azaindole Exceeds Cytotoxicity of Cisplatin at Various Human Cancer Cells and 3D Multicellular Tumor Spheroids

Original language description

The half-sandwich iridium(III) complexes [Ir-(eta(5)-Cp-x)(phaza(-))Cl] (1, 2), [Ir(eta(5)-Cp-x)(thaza(-))Cl] (3, 4), and [Ir(eta(5)-Cp-x)(pyaza)Cl]PF6 (5, 6) containing deprotonated 1-phenyl-7-azaindole (phaza(-)) and 1-(thiophen-2-yl)-7-azaindole (thaza(-)) and electroneutral 1-(pyridin-2-yl)-7-azaindole (pyaza), were prepared; Cp-x = pentamethylcyclopentadienyl (Cp*; for 1, 3, and 5) or 1,2,3,4-tetramethyl-5-phenyl-cyclopentadienyl (Cp-Ph; for 2, 4, and 6). The complexes were thoroughly characterized, including a single-crystal X-ray analysis of complexes 1, 5, and 6. All of the complexes were screened for their in vitro cytotoxicity at the A2780 human ovarian carcinoma cell line and its A2780R cisplatin-resistant variant (2D culture cells). The best-performing complex 6 was further studied against the human DU-145 prostatic carcinoma, A549 lung carcinoma, HCT116 colon carcinoma, HeLa cervix adenocarcinoma, and MCF7 breast adenocarcinoma cell lines (2D culture cells). Complex 6 showed a cytotoxic profile different from that of cisplatin at the used cells, with the highest activity detected at the A2780, MCF7, and HCT116 cells (IC50 = 3.1, 6.9, and 10.4 mu M, respectively). Complex 6 exhibited relevant selectivity toward cancer cells (IC50 = 3.1-13.0 mu M) over the MRC-5 human noncancerous lung fibroblast cells (IC50 &gt; 50.0 mu M). Complex 6 was markedly more accumulated by the A2780 cells in comparison to cisplatin after 24 h exposure. Flow cytometry studies showed that the cell cycle of the A2780 cells treated by complex 6 is modified differently (G(0)/G(1), arrest) in comparison to cisplatin (G(2)/M arrest). Additionally to the monolayer (2D) cancer cell cultures, the cytotoxicity of complex 6 was for the first time among half-sandwich iridium(III) complexes also assessed at spheroid (3D) MCF7 cells, where its potency (IC50 = 22.9 mu M for complex 6) remained significantly better than that for the reference drug cisplatin (IC50 = 35.4 mu M).

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

10402 - Inorganic and nuclear chemistry

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

ORGANOMETALLICS

ISSN

0276-7333

e-ISSN

—

Volume of the periodical

37

Issue of the periodical within the volume

16

Country of publishing house

US - UNITED STATES

Number of pages

11

Pages from-to

2749-2759

UT code for WoS article

000443526200013

EID of the result in the Scopus database

2-s2.0-85052704111